Integra LifeSciences
IART
251 hedge funds and large institutions have $4.8B invested in Integra LifeSciences in 2020 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 83 increasing their positions, 92 reducing their positions, and 15 closing their positions.
107% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 15
40% more capital invested
Capital invested by funds: $3.43B → $4.8B (+$1.38B)
6% more funds holding
Funds holding: 237 → 251 (+14)
1.68% more ownership
Funds ownership: 86.29% → 87.97% (+1.7%)
10% less repeat investments, than reductions
Existing positions increased: 83 | Existing positions reduced: 92
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
37% less call options, than puts
Call options by funds: $2.61M | Put options by funds: $4.13M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$77.6M |
| 2 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
+$42.7M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
+$30.8M |
| 4 |
CB
Cooke & Bieler
Philadelphia,
Pennsylvania
|
+$13.2M |
| 5 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$11.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$38.9M |
| 2 |
Brown Advisory
Baltimore,
Maryland
|
-$24.4M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$15.7M |
| 4 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$13.3M |
| 5 |
Goldman Sachs
New York
|
-$10.3M |
IART Hedge Fund Activity: Q4 2020 in Review
251 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q4 2020, worth a combined $4.8B — up 40% from $3.43B a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new IART positions and 15 closed out — a net gain of 16 holders — while 83 added to existing stakes and 92 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $77.6M. The largest seller was Capital Research Global Investors, cutting an estimated $38.9M.
- 251 institutional investors held Integra LifeSciences (IART) as of Q4 2020, up from 237 in Q3 2020.
- Funds reported $4.8B of Integra LifeSciences stock for Q4 2020, up 40% quarter-over-quarter.
- 31 funds opened new Integra LifeSciences positions in Q4 2020 and 15 closed out, a net change of +16 holders.
- The largest Integra LifeSciences buyer in Q4 2020 was Wellington Management Group, an estimated $77.6M added.
- The largest Integra LifeSciences seller in Q4 2020 was Capital Research Global Investors, an estimated $38.9M sold.
Based on aggregated 13F filings for Q4 2020.